Holen Sie sich die Stockscreener-App
5.87
5.02%
-0.31
Schlusskurs vom Vortag:
$6.18
Offen:
$6.14
24-Stunden-Volumen:
126.03K
Relative Volume:
0.48
Marktkapitalisierung:
$223.28M
Einnahmen:
$239.40M
Nettoeinkommen (Verlust:
$104.44M
KGV:
1.9831
EPS:
2.96
Netto-Cashflow:
$-18.50M
1W Leistung:
-3.61%
1M Leistung:
+15.32%
6M Leistung:
-27.80%
1J Leistung:
-66.70%
1-Tages-Spanne:
$5.67
$6.245
1-Wochen-Bereich:
$5.55
$6.485
52-Wochen-Spanne:
$4.93
$21.79
Entrada Therapeutics Inc Stock (TRDA) Company Profile
Firmenname
Entrada Therapeutics Inc
Sektor
Branche
Telefon
857-305-1825
Adresse
ONE DESIGN CENTER PLACE, BOSTON
Vergleichen Sie TRDA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRDA
Entrada Therapeutics Inc
|
5.87 | 235.07M | 239.40M | 104.44M | -18.50M | 2.96 |
|
VRTX
Vertex Pharmaceuticals Inc
|
416.81 | 104.76B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
481.67 | 63.06B | 2.46B | -319.09M | -52.09M | -2.4669 |
|
REGN
Regeneron Pharmaceuticals Inc
|
578.05 | 60.32B | 14.21B | 4.46B | 3.56B | 39.69 |
|
ARGX
Argen X Se Adr
|
843.66 | 51.55B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
165.76 | 34.49B | 398.11M | -1.03B | -868.57M | -5.7032 |
Entrada Therapeutics Inc Stock (TRDA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-06 | Eingeleitet | ROTH MKM | Buy |
| 2024-01-05 | Eingeleitet | Oppenheimer | Outperform |
| 2023-04-03 | Eingeleitet | H.C. Wainwright | Buy |
Entrada Therapeutics Inc Aktie (TRDA) Neueste Nachrichten
Why Entrada Therapeutics Inc. stock is trending among retail tradersTreasury Yields & Short-Term High Return Ideas - Trung tâm Dự báo KTTV quốc gia
Multi factor analysis applied to Entrada Therapeutics Inc.Weekly Market Summary & Advanced Technical Analysis Signals - newser.com
How interest rate cuts could boost Entrada Therapeutics Inc. stockJuly 2025 Opening Moves & Weekly High Return Opportunities - Trung tâm Dự báo KTTV quốc gia
Is Entrada Therapeutics Inc. forming a bottoming baseJuly 2025 Setups & Trade Opportunity Analysis Reports - newser.com
Applying sector rotation models to Entrada Therapeutics Inc.July 2025 Momentum & AI Enhanced Execution Alerts - newser.com
Sector ETF performance correlation with Entrada Therapeutics Inc.Portfolio Growth Summary & AI Driven Stock Reports - newser.com
What’s the recovery path for long term holders of Entrada Therapeutics Inc.Market Risk Summary & Expert Verified Movement Alerts - newser.com
Best data tools to analyze Entrada Therapeutics Inc. stockPortfolio Update Report & AI Enhanced Execution Alerts - newser.com
Is it time to cut losses on Entrada Therapeutics Inc.July 2025 Pullbacks & Weekly High Conviction Trade Ideas - newser.com
Technical analysis overview for Entrada Therapeutics Inc. stockChart Signals & High Conviction Buy Zone Picks - newser.com
Signal strength of Entrada Therapeutics Inc. stock in tech scanners2025 Geopolitical Influence & Advanced Technical Analysis Signals - newser.com
Entrada Therapeutics, Inc.'s (NASDAQ:TRDA) Shares Bounce 32% But Its Business Still Trails The Industry - simplywall.st
Entrada Therapeutics (NASDAQ:TRDA) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
H.C. Wainwright maintains $20 target on Entrada Therapeutics stock - MSN
Entrada Therapeutics, Inc. (TRDA): Analyst Ratings Signal A 200% Upside Potential - DirectorsTalk Interviews
Analysts Set Entrada Therapeutics, Inc. (NASDAQ:TRDA) Target Price at $25.67 - Defense World
What’s next for Entrada Therapeutics Inc. stock priceStop Loss & Weekly Sector Rotation Insights - newser.com
What high frequency data says about Entrada Therapeutics Inc.Weekly Trend Report & Daily Chart Pattern Signals - newser.com
How to forecast Entrada Therapeutics Inc. trends using time series2025 Institutional Moves & Weekly Breakout Stock Alerts - newser.com
Can swing trading help recover from Entrada Therapeutics Inc. lossesTrade Exit Summary & Low Risk Profit Maximizing Plans - newser.com
Statistical indicators supporting Entrada Therapeutics Inc.’s strengthMarket Trend Summary & Growth Focused Entry Reports - newser.com
Why Entrada Therapeutics Inc. stock is in analyst buy zone2025 Earnings Impact & Low Volatility Stock Recommendations - newser.com
Entrada Therapeutics Inc Stock Analysis and ForecastMarket Rumors and News & Free Trading Psychology Coaching - earlytimes.in
What analysts say about Entrada Therapeutics Inc stockStochastic Oscillator Alerts & Exceptional Capital Trading - earlytimes.in
Finanzdaten der Entrada Therapeutics Inc-Aktie (TRDA)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.84%
0.50%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):